CAS: 18711-13-2 - 4,7-Dichloroisatin
Formula:C8H3Cl2NO2
InChI:InChI=1S/C8H3Cl2NO2/c9-3-1-2-4(10)6-5(3)7(12)8(13)11-6/h1-2H,(H,11,12,13)
InChI key:InChIKey=NUXYYWOWNFEMNH-UHFFFAOYSA-N
SMILES:O=C1NC=2C(Cl)=CC=C(Cl)C2C1=O
- Synonyms:
- 1H-Indole-2,3-dione, 4,7-dichloro-
- 4,7-Dichloroindoline-2,3-dione
- 4,7-dichloro-1H-indole-2,3-dione
- Indole-2,3-dione, 4,7-dichloro-
- Isatin, 4,7-dichloro-
4,7-Dichloroisatin, 98%
CAS:18711-13-2
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. …
Formula:
C8H3Cl2NO2
Purity:
98%
Color and Shape:
Powder, Orange
Molecular weight:
216.02
Ref: 02-A14853
1g | To inquire | ||
5g | 255.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
4,7-Dichloroindoline-2,3-dione
CAS:18711-13-2
Formula:
C8H3Cl2NO2
Purity:
95%
Color and Shape:
Solid
Molecular weight:
216.0209
Ref: IN-DA003KK6
1g | 24.00 € | ||
5g | 54.00 € | ||
25g | 140.00 € | ||
100g | 525.00 € | ||
250mg | 25.00 € |
Estimated delivery in United States, on Thursday 12 Dec 2024
Ref: 54-OR28538
1g | 32.00 € | ||
5g | 42.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024
4,7-Dichloroisatin
CAS:18711-13-2
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
216.02000427246094
Ref: 10-F011141
1g | 20.00 € | ||
5g | 34.00 € | ||
10g | 67.00 € | ||
25g | 151.00 € | ||
100g | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
4,7-Dichloroisatin
CAS:18711-13-2
4,7-Dichloroisatin is an organic compound that is synthesized by ring-opening of oxindole. It is a …
Formula:
C8H3Cl2NO2
Purity:
Min. 95%
Color and Shape:
Solid
Molecular weight:
216.02 g/mol
Ref: 3D-FD60763
5g | 168.00 € | ||
10g | 242.00 € | ||
1kg | 1,950.00 € | ||
25g | 432.00 € | ||
2kg | 3,577.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
4,7-Dichloroisatin
CAS:18711-13-2
Formula:
C8H3Cl2NO2
Purity:
>97.0%(T)
Color and Shape:
Light yellow to Brown powder to crystal
Molecular weight:
216.02
Ref: 3B-D4039
1g | Discontinued | Request information | |
5g | Discontinued | Request information |